Sl.

Product Name

Structure

Molecule details

Cas. No.

Remarks/Uses

Specification

Status

1

2-(4-ethoxybenzyl)-4-bromo-1-chlorobenzene
 

M.F.: C15H14BrClO
Mol. Wt.: 325.63

461432-23-5

Key starting material for the preparation of Dapagliflozin
 

In-House

Commercial

2

(5-bromo-2-chlorophenyl)(4-ethoxyphenyl)methanone

M.F.: C15H12BrClO2
Mol. Wt.: 339.61

461432-22-4

Key starting material for the preparation of Dapagliflozin
 

In-House

Commercial

3

(3R,4S,5R,6R)-3,4,5-tris(trimethylsilyloxy)-6-((trimethylsilyloxy)methyl)-tetrahydropyran-2-one

M.F.: C18H42O6Si4

Mol. Wt.: 466.86

32384-65-9

Uses: It’s a silylated derivative of D-gluconolactone, an intermediate for the preparation of Dapagliflozin, Empagliflozin and Canagliflozin

In-House

Commercial

4

Tafamidis

M.F.: C14H7Cl2NO3

Mol. Wt.: 308.12 g/mol

951395-08-7

Uses: Tafamidis is a key transthyretin (TTR) stabilizer used in the treatment of transthyretin-mediated amyloidosis (ATTR). Its high-purity synthesis is essential due to the molecule’s sensitivity and therapeutic significance, making it a critical API in the rare-disease segment.

In-House

Commercial

5

1-(2,5-Dimethylphenyl)-2-aminoethanol Hydrochloride

M.F.: C10H16ClNO3

Mol. Wt.: 233.69

60407-53-6

Uses: Its an intermediate for the preparation of Midodrine, Midodrine hydrochloride

Under Development

6

2-Amino-1-(2,5-dimethoxyphenyl) ethanol

M.F.: C10H15NO3

Mol. Wt.: 197.23 g/mol

3600-87-1

Uses: 2-Amino-1-(2,5-dimethoxyphenyl)ethanol is an essential advanced intermediate in the synthesis of Midodrine Hydrochloride, a well-established α₁-adrenergic agonist used for the treatment of orthostatic hypotension.

In-House

Under Development